Raluca Budiu-Predoiu

Company: Abbvie

Job title: Director - Precision Medicine

Seminars:

Panel Discussion: Unlocking the Full Potential of Tissue-Free, Methylation-Based Liquid Biopsies to Redefine Monitoring 12:30 pm

The logistical and clinical limitations of tissue-informed methods, including time to treatment, tissue availability, and turnaround time How methylation signatures may offer higher sensitivity and broader applicability than variant tracking alone Considerations for clinical validation, regulatory frameworks, and payer acceptance of tissue-free MRD solutionsRead more

day: Conference Day 1